Paper II
2022 February (2019 Scheme) · 100 marks · 180 min

Question

Epidermal growth factor receptor inhibitors

Q210.2 marksShort Answers

Answer

Erlotinib, Gefitinib — small-molecule tyrosine kinase inhibitors targeting the EGFR intracellular domain, blocking downstream proliferative signaling; used in EGFR-mutant non-small-cell lung cancer.

Other Years Asked


Revise MBBS
Preview